DE60211938D1 - Pharmazeutische zubereitung enthaltend eine kombination aus metformin und a 4-oxobutanonsäure und ihre verwendung zur behandlung von diabetes - Google Patents

Pharmazeutische zubereitung enthaltend eine kombination aus metformin und a 4-oxobutanonsäure und ihre verwendung zur behandlung von diabetes

Info

Publication number
DE60211938D1
DE60211938D1 DE60211938T DE60211938T DE60211938D1 DE 60211938 D1 DE60211938 D1 DE 60211938D1 DE 60211938 T DE60211938 T DE 60211938T DE 60211938 T DE60211938 T DE 60211938T DE 60211938 D1 DE60211938 D1 DE 60211938D1
Authority
DE
Germany
Prior art keywords
alkyl
aryl
metformin
diabetes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60211938T
Other languages
English (en)
Other versions
DE60211938T2 (de
Inventor
Gerard Moinet
Dominique Marais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of DE60211938D1 publication Critical patent/DE60211938D1/de
Application granted granted Critical
Publication of DE60211938T2 publication Critical patent/DE60211938T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DE60211938T 2001-11-28 2002-11-06 Pharmazeutische zusammensetzung enthaltend eine kombination aus metformin und einer 4-oxobutansäure und ihre verwendung zur behandlung von diabetes Expired - Fee Related DE60211938T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115398A FR2832633B1 (fr) 2001-11-28 2001-11-28 Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR0115398 2001-11-28
PCT/EP2002/012355 WO2003045368A1 (en) 2001-11-28 2002-11-06 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes

Publications (2)

Publication Number Publication Date
DE60211938D1 true DE60211938D1 (de) 2006-07-06
DE60211938T2 DE60211938T2 (de) 2007-05-24

Family

ID=8869889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60211938T Expired - Fee Related DE60211938T2 (de) 2001-11-28 2002-11-06 Pharmazeutische zusammensetzung enthaltend eine kombination aus metformin und einer 4-oxobutansäure und ihre verwendung zur behandlung von diabetes

Country Status (22)

Country Link
US (1) US20050020609A1 (de)
EP (1) EP1448181B1 (de)
JP (1) JP2005515984A (de)
KR (1) KR20040058266A (de)
CN (1) CN1592615A (de)
AT (1) ATE327746T1 (de)
AU (1) AU2002351848A1 (de)
BR (1) BR0214487A (de)
CA (1) CA2468280A1 (de)
CY (1) CY1105165T1 (de)
DE (1) DE60211938T2 (de)
DK (1) DK1448181T3 (de)
ES (1) ES2266605T3 (de)
FR (1) FR2832633B1 (de)
HU (1) HUP0402241A2 (de)
MX (1) MXPA04005033A (de)
PL (1) PL369894A1 (de)
PT (1) PT1448181E (de)
RU (1) RU2004119817A (de)
TW (1) TW200300341A (de)
WO (1) WO2003045368A1 (de)
ZA (1) ZA200405021B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117855A1 (ja) * 2004-06-04 2005-12-15 Kowa Company., Ltd. 糖尿病の予防または治療のための薬剤
EP1792580A1 (de) 2005-09-27 2007-06-06 Ziterion GmbH Zweiteilige Dentalimplantate aus biocompatiblen Keramiken
EP1967157A1 (de) 2007-03-05 2008-09-10 Ziterion GmbH Hybrides zweiteiliges Zahnimplantat
EP2106767A1 (de) 2008-03-31 2009-10-07 Ziterion GmbH Zweiteiliges Zahnimplantat
GB201004058D0 (en) * 2010-03-11 2010-04-28 Consiglio Nazionale Ricerche Diagnostic assay for obesity and related disorders
JP2022501340A (ja) * 2018-09-28 2022-01-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー メトホルミンの作用を増強する化合物
CN114349665B (zh) * 2021-11-30 2023-06-09 潍坊博创国际生物医药研究院 二甲双胍焦谷氨酸晶体及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863915A (en) * 1996-05-15 1999-01-26 Bayer Corporation Substituted 4-arylbutyric acid derivatives as matrix metalloprotease
FR2752422B1 (fr) * 1996-08-16 1998-11-06 Lipha Composition pharmaceutique contenant des acides 4-oxo-butanoiques
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
GB9922710D0 (en) * 1999-09-24 1999-11-24 Bayer Ag Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide

Also Published As

Publication number Publication date
PL369894A1 (en) 2005-05-02
EP1448181B1 (de) 2006-05-31
PT1448181E (pt) 2006-10-31
AU2002351848A1 (en) 2003-06-10
ZA200405021B (en) 2005-05-30
CA2468280A1 (en) 2003-06-05
CN1592615A (zh) 2005-03-09
FR2832633A1 (fr) 2003-05-30
KR20040058266A (ko) 2004-07-03
EP1448181A1 (de) 2004-08-25
JP2005515984A (ja) 2005-06-02
FR2832633B1 (fr) 2004-09-24
ATE327746T1 (de) 2006-06-15
BR0214487A (pt) 2004-10-19
CY1105165T1 (el) 2010-03-03
TW200300341A (en) 2003-06-01
WO2003045368A1 (en) 2003-06-05
ES2266605T3 (es) 2007-03-01
MXPA04005033A (es) 2004-08-11
RU2004119817A (ru) 2005-04-20
HUP0402241A2 (hu) 2005-02-28
DK1448181T3 (da) 2006-09-04
DE60211938T2 (de) 2007-05-24
US20050020609A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
AR032781A1 (es) Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen
DE60126947D1 (de) Behandlung der glykogenspeicherkrankheit typ ii
EP1867649A4 (de) Zur inhibierung der freisetzung von tumornecrosefaktor aus zellen verwendete piperidyl-2,6-dionderivate
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
BR0211228A (pt) Composto, composição farmacêutica e seus usos
RU2004100302A (ru) Амиды антраниловой кислоты с гетероарилсульфонильной боковой цепью, способ их получения, их применение в качестве лекарственного или диагностического средства, а также содержащие их фармацевтические композиции
RU2003120080A (ru) Орто-замещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции
JP2004503501A5 (de)
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
PE20040084A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico
DE60211938D1 (de) Pharmazeutische zubereitung enthaltend eine kombination aus metformin und a 4-oxobutanonsäure und ihre verwendung zur behandlung von diabetes
EP1314719A4 (de) Benzoesäurederivate und medikamente die diese als aktiven wirkstoff enthalten
ATE361918T1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE364586T1 (de) Steigerung der wirksamkeit von wirkstoffen durch micellare zubereitung mit retinolderivaten
JP2002003353A (ja) メチオナーゼ及び／又はプロテアーゼ阻害剤及び口腔用組成物
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
RU2008120647A (ru) Оральная композиция, содержащая морин
RU99105208A (ru) Фармацевтическая композиция, содержащая 4-оксобутановые кислоты
EA200701805A1 (ru) Состав аэрозоля для дозирующих ингаляторов под давлением
DE60230629D1 (de) Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
HU0102987D0 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee